TITLE:
Clinical Trial for Prostate Cancer

CONDITION:
Prostate Cancer

INTERVENTION:
Leuprolide Acetate for Injectable Suspension 22.5 mg

SUMMARY:

      Phase III trial using an injectable for treatment of prostate cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 40 Years to N/A
Criteria:
NONE
